Lymphedema after gynecological cancer treatment : Prevalence, correlates, and supportive care needs
Identifieur interne : 007741 ( Main/Exploration ); précédent : 007740; suivant : 007742Lymphedema after gynecological cancer treatment : Prevalence, correlates, and supportive care needs
Auteurs : Vanessa Beesley [Australie] ; Monika Janda [Australie] ; Elizabeth Eakin [Australie] ; Andreas Obermair [Australie] ; Diana Battistutta [Australie]Source :
- Cancer [ 0008-543X ] ; 2007.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Besoins et demandes de services de santé, Facteurs de risque, Femelle, Humains, Lymphoedème (anatomopathologie), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Morbidité, Profil d'impact de la maladie, Prévalence, Qualité de vie, Services de santé, Soins palliatifs, Sujet âgé, Survivants (psychologie), Tumeurs de l'appareil génital féminin (), Tumeurs de l'appareil génital féminin (psychologie), Études transversales.
- MESH :
- anatomopathologie : Lymphoedème.
- psychologie : Survivants, Tumeurs de l'appareil génital féminin.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
- Pascal (Inist)
- Adolescent, Adulte, Adulte d'âge moyen, Besoins et demandes de services de santé, Facteurs de risque, Femelle, Humains, Lymphoedème, Morbidité, Profil d'impact de la maladie, Prévalence, Qualité de vie, Services de santé, Soins palliatifs, Sujet âgé, Traitement, Prévalence, Tumeur maligne, Epidémiologie, Morbidité, Carcinome, Homme, Cancérologie, Cancer, Soin de support, Tumeurs de l'appareil génital féminin, Études transversales.
- Wicri :
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Cancer, Cancerology, Carcinoma, Cross-Sectional Studies, Epidemiology, Female, Genital Neoplasms, Female (complications), Genital Neoplasms, Female (psychology), Genital Neoplasms, Female (therapy), Health Services, Health Services Needs and Demand, Human, Humans, Lymphedema, Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (pathology), Malignant tumor, Middle Aged, Morbidity, Palliative Care, Prevalence, Quality of Life, Risk Factors, Sickness Impact Profile, Supportive care, Survivors (psychology), Treatment.
- MESH :
- complications : Genital Neoplasms, Female.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- pathology : Lymphedema.
- psychology : Genital Neoplasms, Female, Survivors.
- therapy : Genital Neoplasms, Female.
- Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Health Services, Health Services Needs and Demand, Humans, Middle Aged, Morbidity, Palliative Care, Prevalence, Quality of Life, Risk Factors, Sickness Impact Profile.
Abstract
BACKGROUND. Few studies have evaluated lymphedema after gynecological cancer treatment. The aim of this research was to establish prevalence, correlates, and supportive care needs of gynecological cancer survivors who develop lymphedema. METHODS. In 2004, a population-based cross-sectional mail survey (56% response rate) was completed by 802 gynecological cancer survivors. The questionnaire included demographic questions, a validated, generic supportive care needs measure, and a supplementary, newly developed, lymphedema needs module. RESULTS. Ten percent (95% confidence interval [CI], 8%-12%) of participants reported being diagnosed with lymphedema, and a further 15% (95% CI, 13%-17%) reported undiagnosed "symptomatic" lower limb swelling. Diagnosed lymphedema was more prevalent (36%) amongst vulvar cancer survivors. For cervical cancer survivors, those who had radiotherapy or who had lymph nodes removed had higher odds of developing swelling. For uterine and ovarian cancer survivors, those who had lymph nodes removed or who were overweight or obese had higher odds of developing swelling. Gynecological cancer survivors with lymphedema had higher supportive care needs in the information and symptom management domains compared with those who had no swelling. CONCLUSIONS. This population-based study provided evidence that lymphedema is a morbidity experienced by a significant proportion of gynecological cancer survivors and that there are considerable levels of associated unmet needs. Women at risk of lymphedema would benefit from instructions about early signs and symptoms and provision of referral information.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000472
- to stream PascalFrancis, to step Curation: 000488
- to stream PascalFrancis, to step Checkpoint: 000460
- to stream Main, to step Merge: 007904
- to stream PubMed, to step Corpus: 003679
- to stream PubMed, to step Curation: 003679
- to stream PubMed, to step Checkpoint: 003679
- to stream Ncbi, to step Merge: 002682
- to stream Ncbi, to step Curation: 002682
- to stream Ncbi, to step Checkpoint: 002682
- to stream Main, to step Merge: 007346
- to stream Main, to step Curation: 007741
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphedema after gynecological cancer treatment : Prevalence, correlates, and supportive care needs</title><author><name sortKey="Beesley, Vanessa" sort="Beesley, Vanessa" uniqKey="Beesley V" first="Vanessa" last="Beesley">Vanessa Beesley</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Janda, Monika" sort="Janda, Monika" uniqKey="Janda M" first="Monika" last="Janda">Monika Janda</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Eakin, Elizabeth" sort="Eakin, Elizabeth" uniqKey="Eakin E" first="Elizabeth" last="Eakin">Elizabeth Eakin</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Queensland, School of Population Health, Cancer Prevention Research Centre</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>3 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Obermair, Andreas" sort="Obermair, Andreas" uniqKey="Obermair A" first="Andreas" last="Obermair">Andreas Obermair</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Royal Brisbane & Women's Hospital, Queens land Centre for Gynecological Cancer</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of Queensland, School of Medicine</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Battistutta, Diana" sort="Battistutta, Diana" uniqKey="Battistutta D" first="Diana" last="Battistutta">Diana Battistutta</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0282762</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0282762 INIST</idno><idno type="RBID">Pascal:07-0282762</idno><idno type="wicri:Area/PascalFrancis/Corpus">000472</idno><idno type="wicri:Area/PascalFrancis/Curation">000488</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000460</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000460</idno><idno type="wicri:doubleKey">0008-543X:2007:Beesley V:lymphedema:after:gynecological</idno><idno type="wicri:Area/Main/Merge">007904</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17474128</idno><idno type="wicri:Area/PubMed/Corpus">003679</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003679</idno><idno type="wicri:Area/PubMed/Curation">003679</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003679</idno><idno type="wicri:Area/PubMed/Checkpoint">003679</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003679</idno><idno type="wicri:Area/Ncbi/Merge">002682</idno><idno type="wicri:Area/Ncbi/Curation">002682</idno><idno type="wicri:Area/Ncbi/Checkpoint">002682</idno><idno type="wicri:doubleKey">0008-543X:2007:Beesley V:lymphedema:after:gynecological</idno><idno type="wicri:Area/Main/Merge">007346</idno><idno type="wicri:Area/Main/Curation">007741</idno><idno type="wicri:Area/Main/Exploration">007741</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphedema after gynecological cancer treatment : Prevalence, correlates, and supportive care needs</title><author><name sortKey="Beesley, Vanessa" sort="Beesley, Vanessa" uniqKey="Beesley V" first="Vanessa" last="Beesley">Vanessa Beesley</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Janda, Monika" sort="Janda, Monika" uniqKey="Janda M" first="Monika" last="Janda">Monika Janda</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Eakin, Elizabeth" sort="Eakin, Elizabeth" uniqKey="Eakin E" first="Elizabeth" last="Eakin">Elizabeth Eakin</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Queensland, School of Population Health, Cancer Prevention Research Centre</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>3 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Obermair, Andreas" sort="Obermair, Andreas" uniqKey="Obermair A" first="Andreas" last="Obermair">Andreas Obermair</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Royal Brisbane & Women's Hospital, Queens land Centre for Gynecological Cancer</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>University of Queensland, School of Medicine</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Battistutta, Diana" sort="Battistutta, Diana" uniqKey="Battistutta D" first="Diana" last="Battistutta">Diana Battistutta</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Health and Biomedical Innovation</s1><s2>Brisbane</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Cancer</title><title level="j" type="abbreviated">Cancer</title><idno type="ISSN">0008-543X</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Cancer</title><title level="j" type="abbreviated">Cancer</title><idno type="ISSN">0008-543X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Cancer</term><term>Cancerology</term><term>Carcinoma</term><term>Cross-Sectional Studies</term><term>Epidemiology</term><term>Female</term><term>Genital Neoplasms, Female (complications)</term><term>Genital Neoplasms, Female (psychology)</term><term>Genital Neoplasms, Female (therapy)</term><term>Health Services</term><term>Health Services Needs and Demand</term><term>Human</term><term>Humans</term><term>Lymphedema</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Malignant tumor</term><term>Middle Aged</term><term>Morbidity</term><term>Palliative Care</term><term>Prevalence</term><term>Quality of Life</term><term>Risk Factors</term><term>Sickness Impact Profile</term><term>Supportive care</term><term>Survivors (psychology)</term><term>Treatment</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Besoins et demandes de services de santé</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphoedème (anatomopathologie)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Morbidité</term><term>Profil d'impact de la maladie</term><term>Prévalence</term><term>Qualité de vie</term><term>Services de santé</term><term>Soins palliatifs</term><term>Sujet âgé</term><term>Survivants (psychologie)</term><term>Tumeurs de l'appareil génital féminin ()</term><term>Tumeurs de l'appareil génital féminin (psychologie)</term><term>Études transversales</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Genital Neoplasms, Female</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Survivants</term><term>Tumeurs de l'appareil génital féminin</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Genital Neoplasms, Female</term><term>Survivors</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Genital Neoplasms, Female</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Services</term><term>Health Services Needs and Demand</term><term>Humans</term><term>Middle Aged</term><term>Morbidity</term><term>Palliative Care</term><term>Prevalence</term><term>Quality of Life</term><term>Risk Factors</term><term>Sickness Impact Profile</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Besoins et demandes de services de santé</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Morbidité</term><term>Profil d'impact de la maladie</term><term>Prévalence</term><term>Qualité de vie</term><term>Services de santé</term><term>Soins palliatifs</term><term>Sujet âgé</term><term>Traitement</term><term>Prévalence</term><term>Tumeur maligne</term><term>Epidémiologie</term><term>Morbidité</term><term>Carcinome</term><term>Homme</term><term>Cancérologie</term><term>Cancer</term><term>Soin de support</term><term>Tumeurs de l'appareil génital féminin</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Cancer</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND. Few studies have evaluated lymphedema after gynecological cancer treatment. The aim of this research was to establish prevalence, correlates, and supportive care needs of gynecological cancer survivors who develop lymphedema. METHODS. In 2004, a population-based cross-sectional mail survey (56% response rate) was completed by 802 gynecological cancer survivors. The questionnaire included demographic questions, a validated, generic supportive care needs measure, and a supplementary, newly developed, lymphedema needs module. RESULTS. Ten percent (95% confidence interval [CI], 8%-12%) of participants reported being diagnosed with lymphedema, and a further 15% (95% CI, 13%-17%) reported undiagnosed "symptomatic" lower limb swelling. Diagnosed lymphedema was more prevalent (36%) amongst vulvar cancer survivors. For cervical cancer survivors, those who had radiotherapy or who had lymph nodes removed had higher odds of developing swelling. For uterine and ovarian cancer survivors, those who had lymph nodes removed or who were overweight or obese had higher odds of developing swelling. Gynecological cancer survivors with lymphedema had higher supportive care needs in the information and symptom management domains compared with those who had no swelling. CONCLUSIONS. This population-based study provided evidence that lymphedema is a morbidity experienced by a significant proportion of gynecological cancer survivors and that there are considerable levels of associated unmet needs. Women at risk of lymphedema would benefit from instructions about early signs and symptoms and provision of referral information.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Beesley, Vanessa" sort="Beesley, Vanessa" uniqKey="Beesley V" first="Vanessa" last="Beesley">Vanessa Beesley</name></noRegion><name sortKey="Battistutta, Diana" sort="Battistutta, Diana" uniqKey="Battistutta D" first="Diana" last="Battistutta">Diana Battistutta</name><name sortKey="Eakin, Elizabeth" sort="Eakin, Elizabeth" uniqKey="Eakin E" first="Elizabeth" last="Eakin">Elizabeth Eakin</name><name sortKey="Janda, Monika" sort="Janda, Monika" uniqKey="Janda M" first="Monika" last="Janda">Monika Janda</name><name sortKey="Obermair, Andreas" sort="Obermair, Andreas" uniqKey="Obermair A" first="Andreas" last="Obermair">Andreas Obermair</name><name sortKey="Obermair, Andreas" sort="Obermair, Andreas" uniqKey="Obermair A" first="Andreas" last="Obermair">Andreas Obermair</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007741 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007741 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:07-0282762
|texte= Lymphedema after gynecological cancer treatment : Prevalence, correlates, and supportive care needs
}}
| This area was generated with Dilib version V0.6.31. |  |